Since the original demonstration by MagnusLevy (1) of the rise in respiratory exchange after feeding thyroid and the synthesis of thyroxine by Harington and Barger (2), the physiological effects of insufficient and of excess amounts of thyroid hormone have been well described (3). The cellular and biochemical mechanism by which thyroid hormones produce these effects is, however, still far from clear. Numerous studies have shown a direct effect of thyroxine on various in vitro systems (4), but these effects are often difficult to relate to the physiological effects of thyroid hormone.
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The resemblance of the symptoms of hyperthyroidism to the effects of sympathomimetic amines has given rise to the concept that the primary effect of thyroxine may be to alter the tissue sensitivity to epinephrine and norepinephrine. Substantial evidence, both clinical and experimental, has accumulated to support the idea that sensitivity to catecholamines varies directly with the intensity of action of thyroid hormone (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) .
Evidence for the converse hypothesis, i.e., that the tissue response to thyroxine is mediated by the action of catecholamines, is difficult to interpret. It is relatively easy to alter the state of thyroid activity and then test the response to catecholamines. It is far more difficult to remove completely sources of catecholamines before testing the effect of thyroxine. Although many studies (17) (18) (19) (20) (21) (22) (23) have shown an inhibition of the response to thyroxine after removing or inhibiting catecholamines, most of these studies have failed to exclude completely the presence of catecholamines. Other studies (24) (25) (26) (27) (28) have failed to show any change in the effect of thyrox-* Submitted for publication June 7, 1963 ; accepted October 10, 1963. t Postdoctoral fellow of the National Science Foundation. Present address: Department of Medicine, Pratt
Clinic-New England Center Hospital, Boston, Mass. ine when catecholamines have been blocked by various pharmacological agents. Consequently the question of whether thyroxine acts only through its effects on catecholamines remains unsettled.
In an effort to shed further light on this problem, studies using a combination of surgical and pharmacological techniques have been carried out. The effect of thyroid hormones and reserpine independently and in combination on thyroidectomized or thyroidectomized and adrenodemedullated rats has been investigated using metabolic rate, heart rate, and growth as indicators of response.
Methods
Male rates of the hooded or albino strains from the Mill Hill breeding stock were used for thyroidectomy and adrenodemedullation, which was performed under ether anesthesia. Thyroidectomy was done through a mid-line incision (29) , and to destroy any remaining thyroid tissue, 25 to 50 ,uc of I"8 was given 1 week after the operation. Adrenodemedullation, performed through bilateral flank incision at the same time as thyroidectomy, was done by mobilizing the adrenals and incising the capsule. The medulla and cortex were then removed from the capsule by gentle pressure on each side of the adrenal. Tap water was given postoperatively, since in our experience drinking water containing 0.9% sodium chloride did not alter survival. Animals were not used until at least 6 weeks after operation, at which time the hooded rats weighed 148 g and the albino rats 187 g, on the average. At the end of the studies on adrenodemedullated animals the adrenals were removed, homogenized in 10 ml of cold 5% trichloroacetic acid, and centrifuged. The supernatant fluid was assayed for epinephrine by a modification of the method of Crout (30) . With one exception, the epinephrine content was less than 1% of that in the adrenals from normal control animals.
Atropine, epinephrine, and reserpine were obtained from the British Drug Houses." Atropine, 35 Figure 1 ) showed a highly significant effect of thyroxine on growth, no effect of reserpine, and a statistical covariance between the effects of thyroxine and reserpine that was significant at the p = 0.05 level. This occurred because in the rats receiving thyroxine, reserpine slowed growth slightly while the rats receiving no thyroxine grew somewhat more when given reserpine. In experiment 2, a similar study was made on 30 hooded rats. In this experiment 24 thyroidectomized-adrenodemedullated animals were divided into four groups with six rats serving as normal controls. Half of the experimental rats received 8 ug of thyroxine twice weekly. Six thyroxinetreated and six vehicle-treated rats received 25
Ug of reserpine. The remaining groups including normal controls received peanut oil. The hooded rats grew more slowly than the albino rats and showed a smaller response to thyroxine. There was no detectable effect of reserpine.
II. Metabolic rate and heart rate. Two experiments were performed to study the effect of triiodothyronine and reserpine on the oxygen consumption and heart rate of thyroidectomized and thyroidectomized-adrenodemedullated rats. The first experiment on 24 thyroidectomized and 23 thyroidectomized-adrenodemedullated rats is summarized in Table I and Figures 2, 3 , and -4. Twelve thyroidectomized and twelve thyroidectomized-adrenodemedullated rats were used to test the effect of adrenodemedullation on heart rate and oxygen consumption. Six rats from each group were given 10 Mg of triiodothyronine every other day, and the control animals were given an equal volume of alkaline saline. Adrenodemedullation did not alter the mean control values for heart rate and BMR of thyroidectomized rats, nor did it influence the prompt and significant rise in heart rate and BMR after triiodothyronine (Table I , groups 1 to 4). The remaining twelve rats from each group operated on were used to test the effect of reserpine on the rise in heart rate and BMR after triiodothyronine. Six rats from each surgically prepared group received 10 Mg of triiodothyronine on alternate days for 1 week and then daily for a second week and 50 Mg of reserpine daily for 3 days and then on alternate days throughout the remainder of the experiment. (Only two 50-Mg injections of reserpine were given to the thyroidectomized-adrenodemedullated rats, Table I, group 10). As Figure 2 shows, (Table II, The difference between the response of thyroid-0' ectomized and thyroidectomized-adrenodemedul-. lated rats to reserpine alone is shown in Figure 4 (TREATMENT-BEGUN) ( Table II  lo along with the data for group 10 from Table I . The rats receiving the 200-,ug dose showed' a highly significant decline in heart rate with time expressed by the regression equation y = -8x + 11. No rats from either of these groups died or appeared ill during the 2 weeks of this study.
The death of the thyroidectomized-adrenodemedullated rats treated with reserpine led to another study using 30 male hooded rats receiving 10 pg of reserpine (Table III) . A 10-ug dose of reserpine is sufficient to deplete heart catecholamines but probably not other peripheral stores or the brain catecholanlines (33) (34) (35) . The rats were treated for 3 weeks as follows: three thyroidectomized rats and three thyroidectomized-adrenodemedullated rats received 10 ug of triiodothyronine on alternate days for four injections and daily thereafter; six rats from each group received the same course of triiodothyronine plus 10 fig of reserpine in peanut oil intramuscularly for 3 consecutive days and then on alternate days; the remaining rats from each group were divided in half, five receiving NaCl and reserpine, and five receiving NaCl and peanut oil. A comparison of the control data before treatment revealed, as in the previous study, no difference in heart rate or metabolic rate owing to adrenodemedullation. The lower dose of reserpine, like the higher one used previously, was successful in preventing the rise in heart rate that followed triiodothyronine. The rise in oxygen consumption after thyroid was again greater in the rats receiving reserpine. Reserpine, 10 ,ug, did not kill thyroidectomized-adrenodemedullated rats nor did it lower their BMR. It did, however, lower the heart rate significantly, but not progressively.
The failure of the heart rate to rise after treatment with reserpine and triiodothyronine could be due to a direct effect of reserpine on myocardial oxygen consumption or to an indirect ef- To test the possibility that suppression of the heart rate was due to an alteration in the balance between the sympathetic and parasympathetic nervous systems, heart rates were measured before and 1 hour after atropine. In the early studies atropine was administered at 70 mg per 100 g, but in most rats the dose was reduced to 35 mg per 100 g given subcutaneously. A summary of the data is shown in Table V . The highly significant suppression of heart rate produced by reserpine was completely abolished by atropine, and, in additon, there was a significant increase in the heart rate of the rats treated, with only triiodothyronine.
In a final study the effect of guanethidine was investigated. Twelve male albino thyroidectomized-adrenodemedullated rats were divided into three groups. Three rats received guanethidine, 0.5 mg per 100 g, subcutaneously once daily; six received 0.5 mg per 100 g of guanethidine plus 10 /,tg of triiodothyronine daily, and three rats received only triiodothyronine. In the groups receiving triiodothyronine there was a prompt rise in heart rate and BMR that was not affected by guanethidine at 0.5 mg per 100 g ( Figure 5 ). Of the three rats receiving guanethidine alone, one died within 48 hours, a second showed a drop in heart rate and BMR with death after day 6, and the third showed a drop in BMR (from 133 to 54), at which time guanethidine was discontinued; the rat recovered. The experiment was re- peated on three rats that had been thyroidectomized and adrenodemedullated more than 10 weeks previously. The response to 0.5 mg per 100 g of guanethidine on BMR and heart rate of these rats is seen in Figure 6 . All rats were dead within 1 week of beginning guanethidine. Discussion The hypothesis tested in this paper was that the metabolic and hemodynamic manifestations of thyroid hormone were mediated at the tissue level through the action of catecholamines. The data suggest that the extent to which catecholamines are responsible for the manifestations of the thyroid hormone depends on the extent to which the functions measured are normally under adrenergic control. In heart rate the adrenergic component predominates, but in the metabolic rate and probably growth rate the extent of sympathetic control is negligible.
Thyroid hormones induce a rise in heart rate. This tachycardia has been shown to involve all rhythmic elements of the heart (36) and is accompanied by an increased sensitivity to catecholamines (8, 10) and a rise in myocardial oxygen consumption (37) (38) (39) . It can be inhibited by the sympathetic blockade of epidural anesthesia (8) , by reserpine (21, 40) or guanethidine (22, 23) , and by complete heart block (41). It thus seems that the tachycardia of the hyperthyroid state is primarily due to adrenergic stimulation.
The increased myocardial sensitivity to catecholamines induced by thyroid hormones and the ability to inhibit the thyroid-induced tachycardia with techniques that interfere with the sympathetic nervous system suggest that this tachycardia is primarily due to adrenergic stimulation. The effect of reserpine on the heart rate of thyroidtreated rats is consistent with this concept. Reserpine in the doses used in these experiments has been shown to deplete the norepinephrine stores in the heart. The lower dose (10 ,tg given to a 150-g rat) is, however, probably insufficient to deplete brain catecholamines (33) (34) (35) . Both doses lowered heart rate. Adrenodemedullation had no effect. Triiodothyronine raised the depressed heart rate of reserpine-treated rats to control levels, but did not produce any further rise.
The importance of the autonomic nervous system in controlling the heart rate changes after thyroid is further emphasized by the studies with atropine. An increase in sensitivity to cholinergic agents has been demonstrated in hyperthyroid states (42, 43) . Further, it is known that reserpine produces a bradycardia that is overcome by atropine. In the current studies atropine caused a significant rise in heart rate in rats treated with thyroid alone. The same dose of atropine given to hyperthyroid rats receiving reserpine caused a heart-rate rise to the same level as hyperthyroid rats. If reserpine is presumed to inhibit sympathetic nerve transmission by depleting myocardial and nerve supplies of catecholamines, then the bradycardia seen would be the result of a relative increase in vagal activity. By blocking the vagus one would expect the heart rate to rise. It is difficult to explain, however, why both groups reached the same heart rate. One possibility is that the heart rate had reached an intrinsic upper limit determined by its metabolic characteristics.
The ability of reserpine to prevent the tachy-291 cardia produced by thyroid led to an investigation in vitro of the myocardial oxygen consumption of these animals. Other evidence has been reported suggesting that alterations in myocardial oxygen consumption play only a minor role in thyroidinduced changes in heart rate (22) . As seen in Table IV , the threefold rise in heart slice oxygen consumption after thyroid administration was not altered by reserpine. Thus, under physiological conditions, the rate of oxygen consumption by the heart has little or no effect on heart rate changes induced by thyroid in vivo. A case of complete heart block has been reported in which large doses of thyroid raised the BMR and the atrial rate without altering the ventricular rate (41) .
Although the hemodynamic manifestations of thyroid hormones appear to be predominantly under autonomic nervous system control, the effects of thyroid on metabolism are only indirectly under such control. Several studies have shown that thyroid hormones increase the calorigenic action of epinephrine (6, 7, 14) , and some authors have reported that drugs which interfere with sympathetic activity can prevent the rise in oxygen consumption after thyroid (17) (18) (19) (20) . It has not been possible, however, to demonstrate an effect of reserpine on the increase in oxygen consumption produced by triiodothyronine in the experiments reported here, nor was Schwartz (26) able to show an effect of dibenzyline on the rise in oxygen consumption produced by thyroid. Indeed, the administration of reserpine may have enhanced the effect of triiodothyronine on the BMR (Table I , groups 5 vs. 6 and 8 vs. 9; Table II, groups 3 and 4 vs. 5 and 6). Thus, until new evidence is presented, one must conclude that thyroid hormones can raise the metabolic rate independent of the sympathetic nervous system and the catecholamines.
Attempts to show that the sympathetic nervous system has a role in maintaining the BMR in euthyroid animals have also been unsuccessful (28, 44, 45) . If one removes the adrenal medulla and the thyroid, however, it is then possible to depress the hypothyroid BMR and kill rats with either reserpine or guanethidine in doses that have no lethal or BMR-depressing effects in hypothyroid rats with intact adrenal medullas. The basis for this phenomenon is not yet clear. It can be prevented by injections of epinephrine or triiodothyronine. Corticoid production, though not measured, is probably not deficient, since other studies have shown that at the time these animals are used (6 weeks after adrenodemedullation) the adrenal cortex responds normally to stress (46) . It is known from the work of Ring (7) that adrenodemedullation reduces the ability of the rat to increase heat production when exposed to cold. Reserpine has also been shown to reduce the ability of rats to raise their heat production when exposed to lowered ambient temperatures. The careful studies of Adolph and his collaborators (47) have demonstrated a linear relation between body temperature and heart rate or metabolism. Thus, the decrease in heart rate and BMR or reserpine-or guanethidinetreated, thyroidectomized-adrenodemedullated rats may represent a decreased heat production relative to the demands for maintaining body temperature of animals living at room temperature.
The studies on the effect of adrenodemedullation on growth suggest that the catecholamines have a role in the effect of thyroid on growth. These data need to be interpreted with caution. Adrenodemedullation in the rat removes not only the medulla but also the cortex except for the cells lining the capsule. These remaining cells are the source from which the cortex is regenerated. Complete return of normal function, however, requires about 4 weeks. Thus, the observed effect of adrenodemedullation may represent inadequate cortical hormone output during adrenal regeneration. Summary Studies have been carried out to assess the effect of adrenodemedullation and reserpine on the growth rate, metabolic rate, and heart rate of thyroidectomized rats given thyroid. Adrenodemedullation significantly reduced the growth rate, but was without effect on the heart rate or metabolic rate.
The effects of reserpine are complex. It lowered the growth rate slightly of thyroid-treated rats, while raising slightly the growth rate of thyroidectomized rats. Reserpine lowered heart rate of thyroidectomized rats and prevented the tachycardia usually induced by triiodothyronine. This effect on heart rate was abolished by atropine and was not accompanied by any change in the in vitro oxygen consumption of myocardial tissue. Reserl)ine and guanethidine were lethal to thyroidectomized-adrenodemedullated rats but not to rats with intact adrenal medullas. The death of these rats was accompanied by a progressive decline in metabolic rate and heart rate and was prevented by triiodothyronine and epinephrine. These observations are discussed in relation to the thyroid hormones on the control of heart rate and metabolism.
